INSIGHTS ON CLINICAL TRIAL PARTNERING

• Accelerating A Complex Global Cardiovascular Outcomes Trial Via Coordinated Execution

  Coordinating CRO, clinical supply, and central lab activities from the start shaped how a 1,500-site, 35-country cardiovascular outcomes trial moved ahead of plan on activation and enrollment.

• The Role Of Company Culture In FSP Partnerships

  This piece explores intentional culture-building as a strategic asset in FSP engagements, transforming transactional relationships into enduring, high-performing partnerships.

• The Scout Portal Helps Sites Hit SCRS'25 In 25 Goal

  Reducing site training time starts with intuitive tools. Aligning with SCRS’s 25 in 25 goal means eliminating complexity and empowering staff to focus on trial execution.

• Expand Bandwidth With A Trusted Regulatory Writing Partner

  Find out how a mid-size biotech lacking the bandwidth, expertise, and resources to independently handle its regulatory writing requirements overcame this challenge.

• The Future Of Patient Experience: Lessons From GLP-1 Studies

  7/29/2026

  Improve adherence, retention, and data quality in GLP-1 and cardiometabolic trials through connected digital tools, real-time symptom tracking, caregiver support, and AI-assisted review.

• 8 Critical Questions To Ask Your IRB

  2/5/2025

  This article outlines eight essential questions to ask a potential IRB partner to assess their ability to help you navigate complex regulatory requirements while avoiding delays.

• Q&A Workflow Automation To Financial Automation: The Next Step In Scalable Trials

  7/13/2026

  Workflow automation is only part of the solution. Integrating payments, travel, and forecasting with clinical operations supports more efficient trial execution.

• The Realities Reshaping Phase I Trials For Sponsors

  9/15/2026

  Phase I trials increasingly enroll patients and use expansion cohorts. Learn what this shift means for IRB review and sponsor planning.

• Why Trial Expertise Makes Or Breaks Clinical AI

  7/30/2026

  What makes AI effective in clinical trials? See how a top 5 pharma sponsor achieved a 62% reduction in CRA task time and 99% document classification accuracy by prioritizing clinical fluency.